XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Common Stock
Preferred Stock
Series Z preferred stock
Preferred Stock
Series B Preferred Stock
Additional Paid-In Capital
Accumulated Deficit
Other Comprehensive Income (Loss)
Total
Beginning balance at Dec. 31, 2021 $ 3     $ 764,911 $ (735,461)   $ 29,453
Beginning balance (in shares) at Dec. 31, 2021 3,106,947            
Increase (Decrease) in Stockholders' Equity              
Sale of common stock, net of issuance costs       (15)     (15)
Issuance of common stock under employee stock purchase plan       16     16
Issuance of common stock under employee stock purchase plan (in shares) 2,482            
Issuance of common stock under equity incentive plan upon vesting of restricted stock units (in shares) 1,600            
Issuance of common stock for services rendered       22     22
Issuance of common stock for services rendered (in shares) 2,180            
Stock-based compensation expense       545     545
Net loss         (4,178)   (4,178)
Ending balance at Mar. 31, 2022 $ 3     765,479 (739,639)   25,843
Ending balance (in shares) at Mar. 31, 2022 3,113,209            
Temporary equity, Beginning balance at Dec. 31, 2022   $ 27,108          
Temporary equity, Beginning balance (in shares) at Dec. 31, 2022   77,900          
Increase (Decrease) in Temporary Equity              
Vesting of restricted stock awards (in shares)   47          
Conversion of preferred stock to common stock   $ (27,108)          
Conversion of preferred stock to common, shares   (77,947)          
Beginning balance at Dec. 31, 2022 $ 4   $ 1 770,663 (758,821) $ (21) $ 11,826
Beginning balance at Dec. 31, 2022     62,355        
Beginning balance (in shares) at Dec. 31, 2022 3,653,685           3,653,685
Increase (Decrease) in Stockholders' Equity              
Vesting of restricted stock awards (in shares) 6,386            
Issuance of common stock under equity incentive plan upon vesting of restricted stock units and exercise of options       88     $ 88
Issuance of common stock under equity incentive plan upon vesting of restricted stock units and exercise of options (in shares) 55,891            
Issuance of common stock under equity incentive plan for retention payments       456     456
Issuance of common stock under equity incentive plan for retention payments (in shares) 43,900            
Issuance of common stock for services rendered       15     15
Issuance of common stock for services rendered (in shares) 1,972            
Conversion of preferred stock to common stock $ 4   $ (1) 27,105     27,108
Conversion of preferred stock to common stock (in shares) 4,585,115   (62,355)        
Reclassification of warrant liability upon conversion of Series Z Preferred Stock warrants to common stock warrants       3,693     3,693
Stock-based compensation expense       1,231     1,231
Foreign currency translation           (2) (2)
Net loss         (21,867)   (21,867)
Ending balance at Mar. 31, 2023 $ 8     $ 803,251 $ (780,688) $ (23) $ 22,548
Ending balance (in shares) at Mar. 31, 2023 8,346,949           8,346,949